NeoStem Set to Join Multiple Russell Indexes

NEW YORK, June 23, Jun 23, 2014 (GLOBE NEWSWIRE via COMTEX) NeoStem, Inc. (Nasdaq:NBS), a leader in the emerging cellular therapy industry, announced today that it is set to join the broad-market Russell Global, Russell 3000, and Russell Microcap Indexes when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on Friday, June 27, 2014, according to a preliminary list of additions posted June 13 on www.russell.com/indexes. We are very pleased that NeoStem s opportunistic growth strategy, demonstrated through our recent acquisition of California Stem Cell, Inc. (now known as NeoStem Oncology, LLC) and its Targeted Immunotherapy Program, has contributed to the Company s anticipated inclusion in the Russell Global, Russell 3000, and Russell Microcap Indexes, said Dr. Robin L. Smith, Chairman and CEO of NeoStem. We hope that our inclusion in these indexes will increase awareness among investors of NeoStem and our unique platform that includes cell the
http://bit.ly/V5zKXe